Molecular imaging of transcriptional regulation during inflammation
© Kielland and Carlsen; licensee BioMed Central Ltd. 2010
Received: 21 December 2009
Accepted: 26 April 2010
Published: 26 April 2010
Molecular imaging enables non-invasive visualization of the dynamics of molecular processes within living organisms in vivo. Different imaging modalities as MRI, SPECT, PET and optic imaging are used together with molecular probes specific for the biological process of interest. Molecular imaging of transcription factor activity is done in animal models and mostly in transgenic reporter mice, where the transgene essentially consists of a promoter that regulates a reporter gene. During inflammation, the transcription factor NF-κB is widely involved in orchestration and regulation of the immune system and almost all imaging studies in this field has revolved around the role and regulation of NF-κB. We here present a brief introduction to experimental use and design of transgenic reporter mice and a more extensive review of the various studies where molecular imaging of transcriptional regulation has been applied during inflammation.
Historically conventional imaging techniques as radiography, computed tomography, ultrasonography and magnetic resonance imaging (MRI) were developed to visualize anatomical properties and changes for diagnostic purposes. Molecular imaging, which has emerged as a new discipline during the last decade, attempts to visualize functional properties. European Society for Molecular Imaging defines molecular imaging as the characterization of the dynamics of the molecular processes in the living organisms in vivo. The imaging modalities in molecular imaging are SPECT and PET that detect γ- and β- radiation; MRI that detect differences in relaxation time and optical imaging that mainly record luminescent and fluorescent light . Essentially there are two types of molecular methods used in imaging: 1) administration of molecular probes that recognize and bind to a particular biochemical molecule or are activated by a specific process (e.g. enzymatic reaction); 2) reporter genes that are expressed in response to a gene regulatory event. To image activation of transcription factors, most commonly genetic constructs with a promoter coupled to reporter gene are used. This requires introduction of engineered genetic constructs in research animals as in transgenic reporter mice, which has stably integrated the reporter construct in the genome.
Inflammation involves changes in hemodynamics, recruitment of leucocytes and platelets, and release of numerous signaling and effector molecules. All of this is adapted to type of tissue and stimuli (irritant, injury, infection); additionally it is timely regulated and adjusted to severity of insult. Ideally the inflammatory response is initiated on insult and terminated after homeostasis is reestablished. However, inflammation can become chronic, which is the case for diseases like rheumatoid arthritis and inflammatory bowel disease. The complexity of the inflammatory response requires that its many functional elements are controlled coordinately in some situations and independently in others. This regulation occurs through the specificity of recruited immune cells and their differentiation, signaling pathways and gene expression. Cellular protein composition is crucial for regulation at all levels, which gives transcriptional regulation a central role in orchestrating the inflammatory process. It is suggested that various sets of genes encode the different functional elements and that these genes are coordinately regulated by dedicated transcription factors . For instance by using a systems biology approach in an LPS model a combination of three transcription factors (NF-κB, ATF3, CEBP/δ) was demonstrated to coordinate sustained expression of several inflammatory genes . Of these, NF-κB was regarded as the activator and thus illustrates how NF-κB, which is required for most types of inflammatory responses, can engage in regulation of a specific set of inflammatory genes.
There are several hundred transcription factors involved in inflammation. In spite of this, imaging studies of NF-κB has dominated research in this field. NF-κB is attractive for inflammation studies due to the early activation, and the involvement in the large numbers of signaling pathways and the many genes related to immune functions that it controls [4, 5]. The NF-κB family of transcription factors is composed of five members (p50, p52, p65, c-Rel and RelB), which can form various hetero- and homodimers. In resting cells NF-κB is retained in the cytosol bound to Inhibitors of NF-κB (IκBs). Two distinct NF-κB activation pathways have been described, the classical and the alternative pathway. In inflammation, the classical NF-κB pathway is the more important of the two, and it is activated by a large number of stimuli, including proinflammatory cytokines, bacterial and viral products, and stress-inducing stimuli such as γ-radiation, ultraviolet light and reactive oxygen species. These stimuli induce the degradation of IκBα and the nuclear translocation of mainly the p50/p65 heterodimer. In addition to being central for fighting infections and repair of tissue damage, a number of inflammatory diseases have been associated with elevated NF-κB activity including rheumatoid arthritis, inflammatory bowel disease, asthma and cardiovascular disease [6–8]. Furthermore, results from animal models with genetic manipulations that either lead to increased or decreased NF-κB activity demonstrates NF-κB's significance in regulating inflammatory pathologies . Based on such findings the development of NF-κB modulators for treatment of inflammatory diseases has been given a lot of attention.
As imaging of transcription factor activity is basically only examined in transgenic reporter mice, we here briefly describe this technology. Furthermore, we review different studies related to transcription and inflammation, foremost connected to NF-κB.
Design of transgenic reporter mice
Transgenic reporter mice have genomically inserted an engineered DNA construct (called transgene) essentially composed of a promoter and a reporter gene. Studies using reporter mice can determine activity of specific promoters and transcription factors that regulate them, which further can reflect physiological processes, disease progression and experimental manipulations. Reporter mice make possible non-invasive dynamic studies in living animals; meaning that a particular biological process can be monitored both over time and in all organs in the same animal.
Reporter genes are genetic markers that encode easily detectable proteins. The half-life of reporter proteins should be within hours when studying dynamic patterns to obtain close relationship with the biological process. Additionally, a short half-life will prevent accumulation of the reporter caused by potential background activity of the promoter. Extensive accumulation of the reporter can mask an induced expression. In basically all imaging studies of transgenic reporter mice, genes that encode bioluminescent or fluorescent proteins are used . The bioluminescent reporter proteins are enzymes that catalyze a chemical reaction leading to light emission from an injected substrate. The most frequently used is firefly luciferase, but also renilla and click beetle luciferases are proven useful. Due to the scattering properties and absorption spectrum of animal tissue, reporter genes that emit light with the longest wavelength are favorable . For fluorescent reporter genes this is particularly critical since autofluorescence of endogenous molecules is much lower at longer wavelengths. There are many fluorescent reporter genes available and new types are frequently introduced . Recently the first infrared fluorescent protein was engineered . The half-life of the fluorescent proteins are usually rather long, but the carboxy-terminal can be modified to reduce the stability of the protein [14, 15]. Due to tissue autofluorescence, fluorescent imaging has much lower signal-to-noise ratio than bioluminescent imaging. However, fluorescent imaging, is superior for tomographic examination . Optical imaging can be performed with a relatively rapid and easy procedure, which allows high through-put screening.
Co-regulated expression of different types of reporter genes is required to examine the same biological process with different imaging modalities. While bioluminescence is more sensitive in live animal imaging, fluorescent reporters are nearly always necessary for identification of single cells in tissue samples. In clinical imaging, expression of a therapeutic gene can be followed by co-regulated expression of a PET reporter gene . To obtain co-regulated expression of genes various methods are used such as insertion of internal ribosome entry site (IRES) between the genes, repeated use of similar promoters, polyproteins, fusion proteins and bidirectional promoters. IRES is commonly used, but the expression efficiency of the genes on each side of the IRES vary according to the type of transgene and tissue [17, 18]. Multiple promoters are shown to cause mutual interference, which depends on environmental factors . Polyproteins are proteins intermitted with a 2A-like peptide that is "cleaved" during translation . Polyproteins as well as fusion proteins require molecular engineering, which introduce sequence changes that can affect the activity, stability and immunogenicity of the proteins. Bidirectional promoters are naturally occurring in the vertebrate genome, but have not been extensively tested in transgenic models .
Overview of transgenic reporter mice available for studies of inflammation
Regulatory elements of transgenic mice#
Features of the transgenic mice
Three NF-κB sites* separated by linker sequences (14 to 25 bp)
Fluc (Firefly luciferase)
In vivo imaging. Short half-life of reporter. Good induction. Used in numerous disease models. Distinct visualization of lymph nodes.
Difficult to assess single cells
In vivo imaging. Short half-life of reporter. Insulators protect transgene against genomic interference. Used in many disease models.
Difficult to assess single cells.
Six NF-κB sites* separated by four bp. Bi-directional expression of two reporter genes
In vivo imaging and detection of dEGFP in single cells. Short half-life of both reporters. Used in a brain ischemia model.
Weak dEGFP signal. Need antibodies for detection.
In vivo imaging. Short half-life of reporter. Good induction. Used in various disease models mainly to study lung pathology.
Difficult to assess single cells.
HIV-1 LTR with two NF-κB sites* and three Sp1 sites
In vivo imaging. EGFP signal detected in isolated macrophages. Short half-life of both reporters. Good induction.
Need antibodies to detect EGFP in sections.
Good induction. Successfully used to study T-cell regulation.
No demonstration of in vivo imaging.
Five NF-κB sites *
In vivo imaging. Short half-life of reporter.
Used in only one study.
Three NF-κB sites* 
Site specific in HPRT-locus
Signals detected from single cells and whole organs. Site specific integration prevents influence from regulatory elements outside the transgene.
In vivo imaging not shown. Stable version of EGFP complicates assessment of dynamic NF-κB regulation.
In vivo imaging. Used to study TGFβ signaling and response to injury, particularly in brain.
Difficult to assess single cells.
(1.24 kb) 
In vivo imaging. Reflects iNOS mRNA in liver. Sensitive to pro- and anti-inflammatory agents.
Used in only one study.
(11.0 kb) 
In vivo imaging. Luciferase activity reflects IκBα mRNA in liver.
Used in only one study.
SAA1-promoter fragment (7.7 kb) 
In vivo imaging. Luciferase activity reflects SAA1 mRNA in liver and protein in serum. Demonstrated in an acute arthritis model.
Used in only one study.
GADD45β-promoter fragment (10.5 kb) 
In vivo imaging. Reflects GADD45β mRNA in multiple organs. Used to study effects of various stressful insults (inflammation, oxidative stress, toxins).
Used in one study.
Knock-in in the COX2 gene
In vivo imaging. Correlation between luciferase and COX-2 protein levels in multiple organs. Knock-in reflects endogenous promoter activity.
Applications of NF-κB transgenic reporter models
Overview of imaging studies related to transcriptional regulation in inflammation
Type of study
Imaging neural regulation of NF-κB
Hepatic NF-κB is crucial for recruitment of neutrophils to the injured brain .
Vagus nerve signaling regulates NF-κB activity .
Imaging of infection models
In vivo imaging of NF-κB in lung .
NF-κB is sufficient to cause lung inflammation .
Duration of NF-κB activity is determining for lung injury .
NF-κB is induced in infected mammary glands .
NF-κB is central for regulating milk production of mammary glands .
Imaging autoimmune disease
In vivo imaging of NF-κB during arthritis .
Tracking NF-κB in a transgenic model with various autoimmune diseases .
Evaluation of NF-κB inhibitor in arthritis. Combined imaging of NF-κB activity and protease specific near infrared probe .
Evaluation of probe for reactive oxygen species and NF-κB activity in arthritis .
Imaging of dietary influence
NF-κB activity during high fat feeding and obesity .
NF-κB and its role in energy balance of obese mice .
Vitamin A regulates NF-κB activity .
Imaging host immune reaction
Interaction between host and biomaterial induces NF-κB 
Imaging TGFβ signaling
Imaging Smad2/3-dependent TGF-beta signaling reveals prominent tissue-specific responses to inflammatory stimulus and injury .
Orally administered TGF-beta is biologically active in the intestinal mucosa and enhances oral tolerance .
Imaging of Smad signaling shows correlation with excitotoxic neurodegeneration .
Imaging regulation through natural promoters of inflammatory genes
iNOS-promoter activity used to evaluate effect of anti-inflammatory compounds .
Regulation of IκBα expression involves both the NF-κB and MAP kinase signaling pathways .
Serum amyloid A is induced by inflammatory stimuli. NF-κB is an important regulator .
GADD45β-promoter regulation by NF-κB and not MAPK pathway in acute inflammation .
Imaging Cox-2 gene expression in living animals with a luciferase knock-in reporter gene .
Imaging inflammation in non-conventional transgenic mice
NF-κB activation during liver inflammation in mice and prevention by catalase delivery .
Real-time imaging of ligand-induced IKK activation in liver .
Viral delivery of reporter constructs to discrete brain region used to monitor longitudinal NF-κB and AP1 activity .
Imaging neural regulation of NF-κB
Previous observations have shown that following acute brain injury, leukocytes are recruited particularly from the liver to the damaged brain. To test the hypothesis that NF-κB has a critical role in this process, the dynamics of NF-κB activity was imaged after induction of brain injury by intracerebral injection of IL-1β. This led to an exceptionally rapid NF-κB activation in the liver, suggestive of a signal transfer that involves the neural system. To determine the role of hepatic NF-κB, it was selectively inhibited by intravenous adenoviral-mediated delivery of an IκBα super-repressor. This treatment significantly reduced the number of neutrophils recruited to the brain .
The vagus nerve is shown to stimulate anti-inflammatory processes in the gut through cholinergic modulation of macrophages , and in vivo imaging of the gut region after blocking signaling from the vagus nerve by transection showed increased NF-κB activity. Furthermore, in mice with experimentally induced colitis cutting the vagus nerve, and thus removing the cholinergic mediated anti-inflammatory signal, exaggerated the NF-κB activity. This elevated NF-κB activity coincided with disease severity and reduction in regulatory T-cells .
NF-κB imaging in models of infectional diseases
Various constitutively active forms of IκB kinases have been virally introduced in airway epithelium to test whether activation of NF-κB pathways are sufficient to generate lung inflammation . In vivo imaging was used to confirm up-regulation of NF-κB activity in the lung, which also correlated well with disease parameters as cytokines, chemokines and recruitment of neutrophils. Imaging was also used to investigate to what extent duration of NF-κB activation correlated with outcome of lung inflammation . Models of acute or chronic lung infection were induced in reporter mice with single injection or continuous administration of LPS, respectively. NF-κB activation was stronger and more sustained in mice with chronic disease, which progressed into more severe lung injury. Furthermore, an NF-κB inhibitor (BMS-345541), which was delivered after onset of inflammation, reduced disease severity in parallel with reduction in NF-κB activity. Although NF-κB activity clearly correlated with disease outcome in the LPS model described above, two other studies shows that the host defense against Pseudomonas bacterial infection is impaired when NF-κB activity is inhibited experimentally [38, 39].
Mastitis is defined as inflammation of the mammary gland mainly caused by microbial pathogens, such as bacteria. Mastitis is quite common in breast feeding women, and in the dairy industry intra-mammary infections are of great economical importance due to loss of milk production. The dynamics of NF-κB activity was investigated in a mouse model of mastitis where E.coli was inoculated in the mammary glands of lactating mice . NF-κB was rapidly, but transiently activated, with a peak around 10 hours and termination after 24 hours. Interestingly, a systemic response was revealed as a mild increase in NF-κB activity in the liver, which also was longer lasting. This systemic reaction was confirmed by increased circulating levels of the acute phase protein serum amyloid A, tumour necrosis factor-α and interleukin-6. Interestingly, in a recent work it was shown that activation of NF-κB in mammary glands was sufficient to cause mastitis-like symptoms such as increased apoptosis and loss of milk production. Oppositely, specific inhibition of NF-κB in glands of mice with mastitis prevented milk loss . These results indicate that NF-κB is a critical regulator of milk loss during infection, making NF-κB reporter mice useful to evaluate therapeutic strategies.
NF-κB imaging in autoimmune disease
Despite intense research efforts, the etiology of most autoimmune diseases remains obscure. It is previously shown that B-cells can present fragments of the variable region of their immunoglobulins, called idiotype (Id), on their MHC class II, which further can be recognized by T-helper cells. Such T-cells with Id-specific receptors have been described in a number of autoimmune diseases in humans [42–45]. In a mouse model where the collaboration between Id-presenting B-cell and Id-specific T cell are enhanced through genetic manipulation, a plethora of autoimmune diseases correlating with autoantibody production develops . To determine the role of NF-κB during initiation and progression of autoimmune diseases, the mouse model was crossed with NF-κB reporter mice. Imaging revealed NF-κB activation before onset of clinical symptoms and it correlated with disease progression and autoantibody production. Activation was observed in secondary lymphoid organs, inflamed colon, skin lesions, and arthritic joints. Moreover, ex vivo imaging of the small intestine demonstrated autoimmune disease, which had clinical parameters in agreement with celiaki . Additionally, imaging of NF-κB activation has been used to quantify the effect of the IκB kinase 2 inhibitor ML120B in a model of rheumatoid arthritis. This was verified by reduced expression of NF-κB target genes . These results suggest that in vivo imaging of NF-κB activation is a good marker for autoimmune disease in experimental mouse models.
Imaging of NF-κB together with new optical probes
Numerous molecular processes are involved in inflammation and probes that can detect some of these events have been developed. Imaging of NF-κB activation together with such probes has been performed to examine correlation of different but still connected processes. A near infrared fluorescent probe that emits light when cleaved by the protease activity of cathepsin B and K was utilized in a model of rheumatoid arthritis . The intensity of the probe coincided with disease severity and NF-κB mediated luminescence intensity. Production of reactive oxygen species is a hallmark of inflammation. A bioluminescent probe (L-012) that reacts with some of these reactive oxygen species was shown to be activated in parallel with NF-κB in various inflammation models .
NF-κB imaging of dietary influence
The discovery that diet affects gene regulation has been crucial for the understanding of diet's role in health and disease. It has been demonstrated that dietary components can be both pro-inflammatory and anti-inflammatory. Intake of high fat diet can for instance lead to low grade inflammation, which again is linked to metabolic syndrome and type 2 diabetes . In two related studies, NF-κB reporter mice were fed high fat diet for several weeks and both studies found a modest but significant increase in NF-κB dependent bioluminescence, indicative of low grade inflammation [51, 52]. Interestingly, in one of these studies the NF-κB target gene IκBε was chronically elevated, whereas genetic manipulations to inhibit this gene protected against type 2 diabetes . Diet can also contribute to a reduction in inflammation through regulation of NF-κB. Previous studies showed that vitamin A deficiency was linked to increased infection and inflammation. In an attempt to clarify the relationship of vitamin A and NF-κB activity, vitamin A deficient diet were fed to NF-κB reporter mice to deplete the vitamin A stores. Vitamin A deficient mice had an overall increased NF-κB induction of 2.2 fold. Conversely, when mice on normal diet were given a single oral dose of vitamin A in the form of retinoic acid, NF-κB activity was rapidly and transiently decreased . This inhibition was also observed in LPS treated mice . Thus, the use of NF-κB reporting mice may prove to be a powerful tool to evaluate anti-inflammatory effects of other dietary factors.
Imaging TGFβ signaling
Besides NF-κB reporter mice, very few other transgenic reporter models exists for reporting specific transcription factors related to inflammation. One exception is the luciferase reporter mice for the transcription factors Smad 2 and 3 . Activation of these transcription factors is the canonical signaling pathway for transforming growth factor β (TGFβ). TGFβplays a wide role in the immune system, and affects all populations of leukocytes in a stimulatory or inhibitory manner . The Smad reporter mouse was used to assess global regulation of Smad 2 and 3 activities after LPS stimulation. LPS rapidly induced luciferase expression in liver and brain. Moreover, the signal was much more prolonged in the brain demonstrating differences in organ regulation by TGFβ signaling.
Imaging promoter regulation relevant for inflammation
In addition to imaging inflammatory regulation of single transcription factors, several reporter mice have been developed for studies of natural promoters involved in inflammation. Such reporter mice are valuable both for assessing the transcriptional regulation during inflammation and to evaluate the relative contribution of distinct inflammatory genes. Zhang et al., have developed four different transgenic luciferase reporter mice with promoters from important response genes in inflammation: Serum Amyloid A (SAA), inducible Nitric Oxide Synthetase (iNOS), IκB and Growth arrest and DNA-damage-inducible β (GADD45β). In vivo imaging following induction of inflammation by various stimuli showed robust activation in all the reporter mice. In addition they showed, by exploiting specific inhibitors and activators, that NF-κB is central to the regulation of all the promoters. However, the influence of NF-κB differed between the four. The SAA and GADD45β promoter were primarily regulated by NF-κB, whereas the IκB promoter was in addition influenced by the p38 signaling pathway and the iNOS promoter also needed interferon regulated factor for maximal activation [57–60].
Imaging non-conventional transgenic mice
While basically all studies of molecular imaging of transcriptional regulation in inflammations is done in mice produced by pronuclear injection there are some studies with other methods. For instance, transfection and expression of reporter genes can specifically be obtained in liver following intravenous injection of naked DNA. Such an approach has been used to image luciferase activity under the control of NF-κB . In these mice, administration of thioacetamide or LPS showed strong induction of liver bioluminescence and the signal was reduced by catalase. Using the same type of method a fusion protein between firefly luciferase and IκBα was expressed in liver cells. Degradation of IκB is prerequisite for activation of NF-κB. Since degradation of IκB also leads to degradation of firefly luciferase, disappearance of light emission will reflect NF-κB activation . This approach enables a close to real-time imaging of the NF-κB signaling pathway. Another approach is to utilize adenoviral transfection. Brain nuclei have been transfected with reporter constructs for NF-κB and AP1 and imaged in vivo. In this study, luciferase activity could be quantified and followed over several weeks after LPS stimulation .
Conclusion and future perspective
Molecular imaging of transcription factors is a young research field, but has demonstrated the usefulness of visualizing regulation of transcription factors in vivo. We have basically only reviewed studies on NF-κB regulation in inflammation, which have dominated this research area. The various studies illustrate the importance and advantage both to track activity in individual mice over time, to quantify the relative changes in activity and to visualize the spatial patterns of activation.
The present reporter models of NF-κB have provided valuable information in a variety of experiments, but still have potential to elucidate a number of unresolved questions related to inflammation. However, NF-κB, whose binding sites are represented in more than 200 genes, is a rather ubiquitous marker of inflammation and it is also present in genes not directly involved in inflammation. Therefore, development of promoters that are more specifically regulated is attractive in order to investigate distinct functional elements of inflammation. Such promoters must be under regulation of defined sets of transcription factors. An important improvement in this regard will be the ability to more precisely image gene regulation in individual organs, and functional events such as activation of specific cell types and productions of distinct cytokines.
Due to the rapid evolution of imaging technology combined with advances in molecular biology more quantitative and localized characterization of the reporter signal will represent an important and valuable improvement. The studies presented in this review have utilized conventional two dimensional imaging of reporter gene activity, which indeed has created valuable information from distinct organs such as liver, lungs, brain and intestine; however, due to light scattering and poor tissues penetration, it is difficult to localize and quantify signals from deeper lying tissues. Information on inflammation in specific organs is vital for the understanding of biological mechanisms and to validate more precisely the effect of a treatment regime. New developments of brighter versions of optical reporter proteins as well as more red shifted fluorescent proteins is therefore crucial for obtaining tissue specific imaging. The combination of anatomical images (Computer tomography and MRI) with molecular imaging is forthcoming  and will clearly be utilized more extensively in anatomical characterizations. Molecular imaging of transcription factor activity in inflammation will definitively also in the future be an essential tool to provide knowledge in basic biological mechanisms in preclinical studies.
This work was funded by grants from the EU consortium DiMI (LSHB-CT-2005-512146) and the Norwegian Research Council.
- Kang JH, Chung JK: Molecular-genetic imaging based on reporter gene expression. J Nucl Med. 2008, 49 (Suppl 2): 164S-179S. 10.2967/jnumed.107.045955.PubMedView ArticleGoogle Scholar
- Medzhitov R, Horng T: Transcriptional control of the inflammatory response. Nat Rev Immunol. 2009, 9: 692-703. 10.1038/nri2634.PubMedView ArticleGoogle Scholar
- Litvak V, Ramsey SA, Rust AG, Zak DE, Kennedy KA, Lampano AE, Nykter M, Shmulevich I, Aderem A: Function of C/EBPdelta in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals. Nat Immunol. 2009, 10: 437-443. 10.1038/ni.1721.PubMedPubMed CentralView ArticleGoogle Scholar
- Pasparakis M: Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. Nat Rev Immunol. 2009, 9: 778-788. 10.1038/nri2655.PubMedView ArticleGoogle Scholar
- Vallabhapurapu S, Karin M: Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol. 2009, 27: 693-733. 10.1146/annurev.immunol.021908.132641.PubMedView ArticleGoogle Scholar
- Feldmann M, Brennan FM, Maini RN: Rheumatoid arthritis. Cell. 1996, 85: 307-310. 10.1016/S0092-8674(00)81109-5.PubMedView ArticleGoogle Scholar
- Barnes PJ, Adcock IM: Transcription factors and asthma. Eur Respir J. 1998, 12: 221-234. 10.1183/09031936.98.12010221.PubMedView ArticleGoogle Scholar
- Neurath MF, Becker C, Barbulescu K: Role of NF-kappaB in immune and inflammatory responses in the gut. Gut. 1998, 43: 856-860. 10.1136/gut.43.6.856.PubMedPubMed CentralView ArticleGoogle Scholar
- Brinster RL, Allen JM, Behringer RR, Gelinas RE, Palmiter RD: Introns increase transcriptional efficiency in transgenic mice. Proc Natl Acad Sci USA. 1988, 85: 836-840. 10.1073/pnas.85.3.836.PubMedPubMed CentralView ArticleGoogle Scholar
- Gross S, Piwnica-Worms D: Spying on cancer: molecular imaging in vivo with genetically encoded reporters. Cancer Cell. 2005, 7: 5-15.PubMedGoogle Scholar
- Weissleder R, Ntziachristos V: Shedding light onto live molecular targets. Nat Med. 2003, 9: 123-128. 10.1038/nm0103-123.PubMedView ArticleGoogle Scholar
- Shcherbo D, Murphy CS, Ermakova GV, Solovieva EA, Chepurnykh TV, Shcheglov AS, Verkhusha VV, Pletnev VZ, Hazelwood KL, Roche PM, et al.: Far-red fluorescent tags for protein imaging in living tissues. Biochem J. 2009, 418: 567-574. 10.1042/BJ20081949.PubMedPubMed CentralView ArticleGoogle Scholar
- Shu X, Royant A, Lin MZ, Aguilera TA, Lev-Ram V, Steinbach PA, Tsien RY: Mammalian expression of infrared fluorescent proteins engineered from a bacterial phytochrome. Science. 2009, 324: 804-807. 10.1126/science.1168683.PubMedPubMed CentralView ArticleGoogle Scholar
- Li X, Zhao X, Fang Y, Jiang X, Duong T, Fan C, Huang CC, Kain SR: Generation of destabilized green fluorescent protein as a transcription reporter. J Biol Chem. 1998, 273: 34970-34975. 10.1074/jbc.273.52.34970.PubMedView ArticleGoogle Scholar
- Corish P, Tyler-Smith C: Attenuation of green fluorescent protein half-life in mammalian cells. Protein Eng. 1999, 12: 1035-1040. 10.1093/protein/12.12.1035.PubMedView ArticleGoogle Scholar
- Jacobs A, Voges J, Reszka R, Lercher M, Gossmann A, Kracht L, Kaestle C, Wagner R, Wienhard K, Heiss WD: Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet. 2001, 358: 727-729. 10.1016/S0140-6736(01)05904-9.PubMedView ArticleGoogle Scholar
- Borman AM, Le Mercier P, Girard M, Kean KM: Comparison of picornaviral IRES-driven internal initiation of translation in cultured cells of different origins. Nucleic Acids Res. 1997, 25: 925-932. 10.1093/nar/25.5.925.PubMedPubMed CentralView ArticleGoogle Scholar
- Hennecke M, Kwissa M, Metzger K, Oumard A, Kroger A, Schirmbeck R, Reimann J, Hauser H: Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs. Nucleic Acids Res. 2001, 29: 3327-3334. 10.1093/nar/29.16.3327.PubMedPubMed CentralView ArticleGoogle Scholar
- Emerman M, Temin HM: Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell. 1984, 39: 449-467. 10.1016/0092-8674(84)90453-7.PubMedView ArticleGoogle Scholar
- Szymczak AL, Vignali DA: Development of 2A peptide-based strategies in the design of multicistronic vectors. Expert Opin Biol Ther. 2005, 5: 627-638. 10.1517/147125184.108.40.2067.PubMedView ArticleGoogle Scholar
- Amendola M, Venneri MA, Biffi A, Vigna E, Naldini L: Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters. Nat Biotechnol. 2005, 23: 108-116. 10.1038/nbt1049.PubMedView ArticleGoogle Scholar
- Hogan B, Beddington R, Constantini F, Lacy E: Manipulating the mouse embryo. Cold Spring Harbor Laboratory Press. 1994Google Scholar
- Wilson C, Bellen HJ, Gehring WJ: Position effects on eukaryotic gene expression. Annu Rev Cell Biol. 1990, 6: 679-714. 10.1146/annurev.cb.06.110190.003335.PubMedView ArticleGoogle Scholar
- Awatramani R, Soriano P, Mai JJ, Dymecki S: An Flp indicator mouse expressing alkaline phosphatase from the ROSA26 locus. Nat Genet. 2001, 29: 257-259. 10.1038/ng1101-257.PubMedView ArticleGoogle Scholar
- Bronson SK, Plaehn EG, Kluckman KD, Hagaman JR, Maeda N, Smithies O: Single-copy transgenic mice with chosen-site integration. Proc Natl Acad Sci USA. 1996, 93: 9067-9072. 10.1073/pnas.93.17.9067.PubMedPubMed CentralView ArticleGoogle Scholar
- Gaszner M, Felsenfeld G: Insulators: exploiting transcriptional and epigenetic mechanisms. Nat Rev Genet. 2006, 7: 703-713. 10.1038/nrg1925.PubMedView ArticleGoogle Scholar
- Liu F, Song Y, Liu D: Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 1999, 6: 1258-1266. 10.1038/sj.gt.3300947.PubMedView ArticleGoogle Scholar
- Davidson BL, Breakefield XO: Viral vectors for gene delivery to the nervous system. Nat Rev Neurosci. 2003, 4: 353-364. 10.1038/nrn1104.PubMedView ArticleGoogle Scholar
- Prathalingam SR, Howard A, Barley NF, Legon S, Walters JR: Inhibition of luciferase expression from a commercial reporter vector by 1,25-dihydroxycholecalciferol. Anal Biochem. 1998, 263: 113-115. 10.1006/abio.1998.2815.PubMedView ArticleGoogle Scholar
- Kogai T, Kanamoto Y, Brent GA: The modified firefly luciferase reporter gene (luc+) but not Renilla luciferase is induced by all-trans retinoic acid in MCF-7 breast cancer cells. Breast Cancer Res Treat. 2003, 78: 119-126. 10.1023/A:1022179717847.PubMedView ArticleGoogle Scholar
- Sadikot RT, Jansen ED, Blackwell TR, Zoia O, Yull F, Christman JW, Blackwell TS: High-dose dexamethasone accentuates nuclear factor-kappa b activation in endotoxin-treated mice. Am J Respir Crit Care Med. 2001, 164: 873-878.PubMedView ArticleGoogle Scholar
- Carlsen H, Moskaug JO, Fromm SH, Blomhoff R: In vivo imaging of NF-kappa B activity. J Immunol. 2002, 168: 1441-1446.PubMedView ArticleGoogle Scholar
- Campbell SJ, Anthony DC, Oakley F, Carlsen H, Elsharkawy AM, Blomhoff R, Mann DA: Hepatic nuclear factor kappa B regulates neutrophil recruitment to the injured brain. J Neuropathol Exp Neurol. 2008, 67: 223-230. 10.1097/NEN.0b013e3181654957.PubMedView ArticleGoogle Scholar
- Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Yang H, Ulloa L, Al-Abed Y, et al.: Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003, 421: 384-388. 10.1038/nature01339.PubMedView ArticleGoogle Scholar
- O'Mahony C, Kleij van der H, Bienenstock J, Shanahan F, O'Mahony L: Loss of vagal anti-inflammatory effect: in vivo visualization and adoptive transfer. Am J Physiol Regul Integr Comp Physiol. 2009, 297: R1118-1126.PubMedView ArticleGoogle Scholar
- Sadikot RT, Han W, Everhart MB, Zoia O, Peebles RS, Jansen ED, Yull FE, Christman JW, Blackwell TS: Selective I kappa B kinase expression in airway epithelium generates neutrophilic lung inflammation. J Immunol. 2003, 170: 1091-1098.PubMedView ArticleGoogle Scholar
- Everhart MB, Han W, Sherrill TP, Arutiunov M, Polosukhin VV, Burke JR, Sadikot RT, Christman JW, Yull FE, Blackwell TS: Duration and intensity of NF-kappaB activity determine the severity of endotoxin-induced acute lung injury. J Immunol. 2006, 176: 4995-5005.PubMedView ArticleGoogle Scholar
- Sadikot RT, Zeng H, Yull FE, Li B, Cheng DS, Kernodle DS, Jansen ED, Contag CH, Segal BH, Holland SM, et al.: p47phox deficiency impairs NF-kappa B activation and host defense in Pseudomonas pneumonia. J Immunol. 2004, 172: 1801-1808.PubMedView ArticleGoogle Scholar
- Sadikot RT, Zeng H, Joo M, Everhart MB, Sherrill TP, Li B, Cheng DS, Yull FE, Christman JW, Blackwell TS: Targeted immunomodulation of the NF-kappaB pathway in airway epithelium impacts host defense against Pseudomonas aeruginosa. J Immunol. 2006, 176: 4923-4930.PubMedView ArticleGoogle Scholar
- Notebaert S, Carlsen H, Janssen D, Vandenabeele P, Blomhoff R, Meyer E: In vivo imaging of NF-kappaB activity during Escherichia coli-induced mammary gland infection. Cell Microbiol. 2008, 10: 1249-1258. 10.1111/j.1462-5822.2008.01123.x.PubMedView ArticleGoogle Scholar
- Connelly L, Barham W, Pigg R, Saint-Jean L, Sherrill T, Cheng DS, Chodosh LA, Blackwell TS, Yull FE: Activation of nuclear factor kappa B in mammary epithelium promotes milk loss during mammary development and infection. J Cell Physiol. 2010, 222: 73-81. 10.1002/jcp.21922.PubMedPubMed CentralView ArticleGoogle Scholar
- Williams WM, Staines NA, Muller S, Isenberg DA: Human T cell responses to autoantibody variable region peptides. Lupus. 1995, 4: 464-471. 10.1177/096120339500400608.PubMedView ArticleGoogle Scholar
- Dayan M, Segal R, Sthoeger Z, Waisman A, Brosh N, Elkayam O, Eilat E, Fridkin M, Mozes E: Immune response of SLE patients to peptides based on the complementarity determining regions of a pathogenic anti-DNA monoclonal antibody. J Clin Immunol. 2000, 20: 187-194. 10.1023/A:1006685413157.PubMedView ArticleGoogle Scholar
- van Schooten WC, Devereux D, Ho CH, Quan J, Aguilar BA, Rust CJ: Joint-derived T cells in rheumatoid arthritis react with self-immunoglobulin heavy chains or immunoglobulin-binding proteins that copurify with immunoglobulin. Eur J Immunol. 1994, 24: 93-98. 10.1002/eji.1830240115.PubMedView ArticleGoogle Scholar
- Holmoy T, Fredriksen AB, Thompson KM, Hestvik AL, Bogen B, Vartdal F: Cerebrospinal fluid T cell clones from patients with multiple sclerosis: recognition of idiotopes on monoclonal IgG secreted by autologous cerebrospinal fluid B cells. Eur J Immunol. 2005, 35: 1786-1794. 10.1002/eji.200425417.PubMedView ArticleGoogle Scholar
- Munthe LA, Corthay A, Os A, Zangani M, Bogen B: Systemic autoimmune disease caused by autoreactive B cells that receive chronic help from Ig V region-specific T cells. J Immunol. 2005, 175: 2391-2400.PubMedView ArticleGoogle Scholar
- Zangani M, Carlsen H, Kielland A, Os A, Hauglin H, Blomhoff R, Munthe LA, Bogen B: Tracking early autoimmune disease by bioluminescent imaging of NF-kappaB activation reveals pathology in multiple organ systems. Am J Pathol. 2009, 174: 1358-1367. 10.2353/ajpath.2009.080700.PubMedPubMed CentralView ArticleGoogle Scholar
- Izmailova ES, Paz N, Alencar H, Chun M, Schopf L, Hepperle M, Lane JH, Harriman G, Xu Y, Ocain T, et al.: Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis. Arthritis Rheum. 2007, 56: 117-128. 10.1002/art.22303.PubMedView ArticleGoogle Scholar
- Kielland A, Blom T, Nandakumar KS, Holmdahl R, Blomhoff R, Carlsen H: In vivo imaging of reactive oxygen and nitrogen species in inflammation using the luminescent probe L-012. Free Radic Biol Med. 2009, 47: 760-766. 10.1016/j.freeradbiomed.2009.06.013.PubMedView ArticleGoogle Scholar
- Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M: IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med. 2005, 11: 191-198. 10.1038/nm1185.PubMedView ArticleGoogle Scholar
- Carlsen H, Haugen F, Zadelaar S, Kleemann R, Kooistra T, Drevon CA, Blomhoff R: Diet-induced obesity increases NF-kappaB signaling in reporter mice. Genes Nutr. 2009, 4: 215-222. 10.1007/s12263-009-0133-6.PubMedPubMed CentralView ArticleGoogle Scholar
- Chiang SH, Bazuine M, Lumeng CN, Geletka LM, Mowers J, White NM, Ma JT, Zhou J, Qi N, Westcott D, et al.: The protein kinase IKKepsilon regulates energy balance in obese mice. Cell. 2009, 138: 961-975. 10.1016/j.cell.2009.06.046.PubMedPubMed CentralView ArticleGoogle Scholar
- Austenaa LM, Carlsen H, Ertesvag A, Alexander G, Blomhoff HK, Blomhoff R: Vitamin A status significantly alters nuclear factor-kappaB activity assessed by in vivo imaging. Faseb J. 2004, 18: 1255-1257.PubMedGoogle Scholar
- Austenaa LM, Carlsen H, Hollung K, Blomhoff HK, Blomhoff R: Retinoic acid dampens LPS-induced NF-kappaB activity: results from human monoblasts and in vivo imaging of NF-kappaB reporter mice. J Nutr Biochem. 2009, 20: 726-734. 10.1016/j.jnutbio.2008.07.002.PubMedView ArticleGoogle Scholar
- Lin AH, Luo J, Mondshein LH, ten Dijke P, Vivien D, Contag CH, Wyss-Coray T: Global analysis of Smad2/3-dependent TGF-beta signaling in living mice reveals prominent tissue-specific responses to injury. J Immunol. 2005, 175: 547-554.PubMedView ArticleGoogle Scholar
- Rubtsov YP, Rudensky AY: TGFbeta signalling in control of T-cell-mediated self-reactivity. Nat Rev Immunol. 2007, 7: 443-453. 10.1038/nri2095.PubMedView ArticleGoogle Scholar
- Zhang N, Weber A, Li B, Lyons R, Contag PR, Purchio AF, West DB: An inducible nitric oxide synthase-luciferase reporter system for in vivo testing of anti-inflammatory compounds in transgenic mice. J Immunol. 2003, 170: 6307-6319.PubMedView ArticleGoogle Scholar
- Zhang N, Ahsan MH, Zhu L, Sambucetti LC, Purchio AF, West DB: Regulation of IkappaBalpha expression involves both NF-kappaB and the MAP kinase signaling pathways. J Inflamm (Lond). 2005, 2: 10-10.1186/1476-9255-2-10.View ArticleGoogle Scholar
- Zhang N, Ahsan MH, Purchio AF, West DB: Serum amyloid A-luciferase transgenic mice: response to sepsis, acute arthritis, and contact hypersensitivity and the effects of proteasome inhibition. J Immunol. 2005, 174: 8125-8134.PubMedView ArticleGoogle Scholar
- Zhang N, Ahsan MH, Zhu L, Sambucetti LC, Purchio AF, West DB: NF-kappaB and not the MAPK signaling pathway regulates GADD45beta expression during acute inflammation. J Biol Chem. 2005, 280: 21400-21408. 10.1074/jbc.M411952200.PubMedView ArticleGoogle Scholar
- Hyoudou K, Nishikawa M, Kobayashi Y, Kuramoto Y, Yamashita F, Hashida M: Analysis of in vivo nuclear factor-kappaB activation during liver inflammation in mice: prevention by catalase delivery. Mol Pharmacol. 2007, 71: 446-453. 10.1124/mol.106.027169.PubMedView ArticleGoogle Scholar
- Gross S, Piwnica-Worms D: Real-time imaging of ligand-induced IKK activation in intact cells and in living mice. Nat Methods. 2005, 2: 607-614. 10.1038/nmeth779.PubMedView ArticleGoogle Scholar
- Peterson JR, Infanger DW, Braga VA, Zhang Y, Sharma RV, Engelhardt JF, Davisson RL: Longitudinal noninvasive monitoring of transcription factor activation in cardiovascular regulatory nuclei using bioluminescence imaging. Physiol Genomics. 2008, 33: 292-299. 10.1152/physiolgenomics.00296.2007.PubMedView ArticleGoogle Scholar
- Kruttwig K, Brueggemann C, Kaijzel E, Vorhagen S, Hilger T, Lowik C, Hoehn M: Development of a Three-Dimensional In Vitro Model for Longitudinal Observation of Cell Behavior: Monitoring by Magnetic Resonance Imaging and Optical Imaging. Mol Imaging Biol. 2009,Google Scholar
- Didierlaurent A, Ferrero I, Otten LA, Dubois B, Reinhardt M, Carlsen H, Blomhoff R, Akira S, Kraehenbuhl JP, Sirard JC: Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response. J Immunol. 2004, 172: 6922-6930.PubMedView ArticleGoogle Scholar
- Smeets RL, Joosten LA, Arntz OJ, Bennink MB, Takahashi N, Carlsen H, Martin MU, Berg van den WB, Loo van de FA: Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist. Arthritis Rheum. 2005, 52: 2202-2211. 10.1002/art.21108.PubMedView ArticleGoogle Scholar
- Vykhovanets EV, Shukla S, MacLennan GT, Resnick MI, Carlsen H, Blomhoff R, Gupta S: Molecular imaging of NF-kappaB in prostate tissue after systemic administration of IL-1 beta. Prostate. 2008, 68: 34-41. 10.1002/pros.20666.PubMedView ArticleGoogle Scholar
- Ruusalepp A, Yan ZQ, Carlsen H, Czibik G, Hansson GK, Moskaug JO, Blomhoff R, Valen G: Gene deletion of NF-kappaB p105 enhances neointima formation in a mouse model of carotid artery injury. Cardiovasc Drugs Ther. 2006, 20: 103-111. 10.1007/s10557-006-6755-7.PubMedView ArticleGoogle Scholar
- Alexander G, Carlsen H, Blomhoff R: Strong in vivo activation of NF-kappaB in mouse lenses by classic stressors. Invest Ophthalmol Vis Sci. 2003, 44: 2683-2688. 10.1167/iovs.02-0829.PubMedView ArticleGoogle Scholar
- Alexander G, Carlsen H, Blomhoff R: Corneal NF-kappaB activity is necessary for the retention of transparency in the cornea of UV-B-exposed transgenic reporter mice. Exp Eye Res. 2006, 82: 700-709. 10.1016/j.exer.2005.09.012.PubMedView ArticleGoogle Scholar
- Didierlaurent AM, Morel S, Lockman L, Giannini SL, Bisteau M, Carlsen H, Kielland A, Vosters O, Vanderheyde N, Schiavetti F, et al.: AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity. J Immunol. 2009, 183: 6186-6197. 10.4049/jimmunol.0901474.PubMedView ArticleGoogle Scholar
- Dohlen G, Carlsen H, Blomhoff R, Thaulow E, Saugstad OD: Reoxygenation of hypoxic mice with 100% oxygen induces brain nuclear factor-kappa B. Pediatr Res. 2005, 58: 941-945. 10.1203/01.PDR.0000182595.62545.EE.PubMedView ArticleGoogle Scholar
- Dohlen G, Odland HH, Carlsen H, Blomhoff R, Thaulow E, Saugstad OD: Antioxidant activity in the newborn brain: a luciferase mouse model. Neonatology. 2008, 93: 125-131. 10.1159/000107777.PubMedView ArticleGoogle Scholar
- Ertesvag A, Austenaa LM, Carlsen H, Blomhoff R, Blomhoff HK: Retinoic acid inhibits in vivo interleukin-2 gene expression and T-cell activation in mice. Immunology. 2009, 126: 514-522. 10.1111/j.1365-2567.2008.02913.x.PubMedPubMed CentralView ArticleGoogle Scholar
- Partridge J, Carlsen H, Enesa K, Chaudhury H, Zakkar M, Luong L, Kinderlerer A, Johns M, Blomhoff R, Mason JC, et al.: Laminar shear stress acts as a switch to regulate divergent functions of NF-kappaB in endothelial cells. Faseb J. 2007, 21: 3553-3561. 10.1096/fj.06-8059com.PubMedView ArticleGoogle Scholar
- Tillmanns J, Carlsen H, Blomhoff R, Valen G, Calvillo L, Ertl G, Bauersachs J, Frantz S: Caught in the act: in vivo molecular imaging of the transcription factor NF-kappaB after myocardial infarction. Biochem Biophys Res Commun. 2006, 342: 773-774. 10.1016/j.bbrc.2006.02.024.PubMedView ArticleGoogle Scholar
- Kielland A, Camassa LA, Munthe LA, Amiry-Moghaddam M, Blomhoff R, Carlsen H: NF-kB is upregulated in endothelial cells in brain following ischemia. Manuscript. 2010,Google Scholar
- Blackwell TS, Yull FE, Chen CL, Venkatakrishnan A, Blackwell TR, Hicks DJ, Lancaster LH, Christman JW, Kerr LD: Use of genetically altered mice to investigate the role of nuclear factor-kappa B activation and cytokine gene expression in sepsis-induced ARDS. Chest. 1999, 116: 73S-74S. 10.1378/chest.116.suppl_1.73S.PubMedView ArticleGoogle Scholar
- Blackwell TS, Yull FE, Chen CL, Venkatakrishnan A, Blackwell TR, Hicks DJ, Lancaster LH, Christman JW, Kerr LD: Multiorgan nuclear factor kappa B activation in a transgenic mouse model of systemic inflammation. Am J Respir Crit Care Med. 2000, 162: 1095-1101.PubMedView ArticleGoogle Scholar
- Sadikot RT, Wudel LJ, Jansen DE, Debelak JP, Yull FE, Christman JW, Blackwell TS, Chapman WC: Hepatic cryoablation-induced multisystem injury: bioluminescent detection of NF-kappaB activation in a transgenic mouse model. J Gastrointest Surg. 2002, 6: 264-270. 10.1016/S1091-255X(01)00064-6.PubMedView ArticleGoogle Scholar
- Stathopoulos GT, Sherrill TP, Han W, Sadikot RT, Yull FE, Blackwell TS, Fingleton B: Host nuclear factor-kappaB activation potentiates lung cancer metastasis. Mol Cancer Res. 2008, 6: 364-371. 10.1158/1541-7786.MCR-07-0309.PubMedView ArticleGoogle Scholar
- Gray KD, Simovic MO, Chapman WC, Blackwell TS, Christman JW, Washington MK, Yull FE, Jaffal N, Jansen ED, Gautman S, Stain SC: Systemic nf-kappaB activation in a transgenic mouse model of acute pancreatitis. J Surg Res. 2003, 110: 310-314. 10.1016/S0022-4804(03)00024-6.PubMedView ArticleGoogle Scholar
- Jimi E, Phillips RJ, Rincon M, Voll R, Karasuyama H, Flavell R, Ghosh S: Activation of NF-kappaB promotes the transition of large, CD43+ pre-B cells to small, CD43- pre-B cells. Int Immunol. 2005, 17: 815-825. 10.1093/intimm/dxh263.PubMedView ArticleGoogle Scholar
- Millet I, Phillips RJ, Sherwin RS, Ghosh S, Voll RE, Flavell RA, Vignery A, Rincon M: Inhibition of NF-kappaB activity and enhancement of apoptosis by the neuropeptide calcitonin gene-related peptide. J Biol Chem. 2000, 275: 15114-15121. 10.1074/jbc.275.20.15114.PubMedView ArticleGoogle Scholar
- Voll RE, Jimi E, Phillips RJ, Barber DF, Rincon M, Hayday AC, Flavell RA, Ghosh S: NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. Immunity. 2000, 13: 677-689. 10.1016/S1074-7613(00)00067-4.PubMedView ArticleGoogle Scholar
- Hubbard AK, Timblin CR, Shukla A, Rincon M, Mossman BT: Activation of NF-kappaB-dependent gene expression by silica in lungs of luciferase reporter mice. Am J Physiol Lung Cell Mol Physiol. 2002, 282: L968-975.PubMedView ArticleGoogle Scholar
- Ho TY, Chen YS, Hsiang CY: Noninvasive nuclear factor-kappaB bioluminescence imaging for the assessment of host-biomaterial interaction in transgenic mice. Biomaterials. 2007, 28: 4370-4377. 10.1016/j.biomaterials.2007.07.005.PubMedView ArticleGoogle Scholar
- Magness ST, Jijon H, Van Houten Fisher N, Sharpless NE, Brenner DA, Jobin C: In vivo pattern of lipopolysaccharide and anti-CD3-induced NF-kappa B activation using a novel gene-targeted enhanced GFP reporter gene mouse. J Immunol. 2004, 173: 1561-1570.PubMedView ArticleGoogle Scholar
- Ando T, Hatsushika K, Wako M, Ohba T, Koyama K, Ohnuma Y, Katoh R, Ogawa H, Okumura K, Luo J: Orally administered TGF-beta is biologically active in the intestinal mucosa and enhances oral tolerance. J Allergy Clin Immunol. 2007, 120: 916-923. 10.1016/j.jaci.2007.05.023.PubMedView ArticleGoogle Scholar
- Luo J, Lin AH, Masliah E, Wyss-Coray T: Bioluminescence imaging of Smad signaling in living mice shows correlation with excitotoxic neurodegeneration. Proc Natl Acad Sci USA. 2006, 103: 18326-18331. 10.1073/pnas.0605077103.PubMedPubMed CentralView ArticleGoogle Scholar
- Ishikawa TO, Herschman HR: Tumor formation in a mouse model of colitis associated colon cancer does not require COX-1 or COX-2 expression. Carcinogenesis. 2010Google Scholar
- Ishikawa TO, Jain N, Herschman HR: Feedback regulation of cyclooxygenase-2 transcription ex vivo and in vivo. Biochem Biophys Res Commun. 2009, 378: 534-538. 10.1016/j.bbrc.2008.11.099.PubMedPubMed CentralView ArticleGoogle Scholar
- Ishikawa TO, Jain NK, Taketo MM, Herschman HR: Imaging cyclooxygenase-2 (Cox-2) gene expression in living animals with a luciferase knock-in reporter gene. Mol Imaging Biol. 2006, 8: 171-187. 10.1007/s11307-006-0034-7.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.